Even As Observers Write Its Obituary, Theranos Pushes Expansion Narrative
The bedeviled blood-testing startup has posted 200 job openings and has recently made several higher-level moves as well.
The independent source for health policy research, polling, and news.
37,661 - 37,680 of 112,590 Results
The bedeviled blood-testing startup has posted 200 job openings and has recently made several higher-level moves as well.
In 2013, the Food and Drug Administration proposed changing labeling rules to “create parity” between generic and brand-name drug makers for how they update their labels, exposing generic companies to legal liability if they failed to properly warn of a drug’s risks. The agency has announced it has decided to put off the decision until 2017.
Gov. Mary Fallin has five days to sign the bill into law or veto it. Critics see the move as largely symbolic as they predict it will face a constitutional challenge in court. "I think it is silly for us to pass bills in Oklahoma that can't go anywhere," said Republican state Sen. Ervin Yen.
The survey by the Kaiser Family Foundation identifies rising concerns about the prices for medical services and insurance.
The agency says the new limits were prompted by recent scientific studies linking perfluorooctanoic acid and perfluorooctane sulfonate to testicular and kidney cancers, as well as birth defects and liver damage.
Meanwhile, lawmakers reach an agreement on efforts to overhaul chemical safety laws, and two GOP senators advance legislation to reform the agency that provides health care to Native Americans.
The key difference between the competing versions of the bills is that House GOP conservatives insisted that spending cuts accompany the measure so that its cost isn't added to the budget deficit.
Democratic presidential candidate Hillary Clinton has proposed that some older Americans be allowed to buy into Medicare early. A study by the consulting group Avalere says that could interest as many as 7 million people who are uninsured and about 6 million who buy coverage on the health law's marketplaces. Meanwhile, one policy organization revises its estimate of the cost of Sen. Bernie Sanders' health plan.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Outlets report on health news in Georgia, Illinois, Oklahoma, Tennessee, Virginia, Colorado, South Carolina, Iowa, Florida and Ohio.
The cuts to the health program serving low-income residents include a reduction in reimbursements to doctors and hospitals.
News outlets also report on hospital-related news from California, Kansas, Missouri, North Carolina and Maryland.
In a new study, cancer patients whose tumor bloomed on the left side of their colon survived a median of 33.3 months, while right-sided colon cancer patients survived 19.4 months.
Traits such as intense focus and facility with numbers and patterns can be a huge asset to companies. In other public health news, gay and bisexual men in the South have particularly high HIV rates, pediatricians are urged to ask about families' financial struggles, scientists hope part-human, party-animal embryos could one day save lives, and a new study finds that a busy schedule might have positive effects on the brain.
Although Congress has passed an opioid package that includes such things as bolstering prescription drug monitoring and funding drug disposal efforts, it also sent through a measure that limits the Drug Enforcement Administration's powers to pursue pharmacies and wholesalers that the agency believes have contributed to the epidemic.
South Carolina's 20-week ban is just the latest measure to limit abortion access in the states. Meanwhile, in Ohio, a law stripping funding from Planned Parenthood is causing some officials to scramble to find replacement services.
Meanwhile, The Wall Street Journal reports on a new study that offers hope to melanoma patients. Also, the Food and Drug Administration approves a new therapy for advanced bladder cancer and The Washington Post details a new analysis regarding colon cancer.
The startup voided two years of results and revised other reports in an effort to stave off harsh sanctions from the Centers for Medicare & Medicaid Services.
© 2026 KFF